Molecular Imaging of Newly Diagnosed Prostate Cancer

被引：4

作者：

Williams, Scott ^{[1
,2
]}

机构：

[1] Peter MacCallum Canc Ctr, Div Radiat Oncol, 305 Grattan St, Melbourne, Vic 3000, Australia

[2] Univ Melbourne, Div Radiat Oncol, Melbourne, Vic, Australia

来源：

CANCER JOURNAL | 2020年 / 26卷 / 01期

关键词：

Positron emission tomography; prostate cancer; prostate-specific membrane antigen; POSITRON-EMISSION-TOMOGRAPHY; MEMBRANE ANTIGEN-EXPRESSION; GA-68-PSMA PET/CT; C-11-CHOLINE PET/CT; METASTASES; CARCINOMA; ACID; VALIDATION; RECURRENCE; ACCURACY;

D O I：

10.1097/PPO.0000000000000427

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) is a valuable imaging in evaluating many malignancies. There are various molecular imaging tracers that are currently being utilized with prostate cancer (PC). Several PET agents imaging different molecular processes in PC have reached the clinic. While all of these agents have demonstrated an advantage over conventional imaging, there are considerable differences in the performance of each in staging newly diagnosed PC. In this article, we review the current updates available of different PET tracers, with a strong focus on the emerging role of prostate-specific membrane antigen PET in the management of newly diagnosed PC.

引用

页码：43 / 47

页数：5

共 50 条

[31] Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
Buelens, Sarah
De Bleser, Elise
Dhondt, Bert
Verla, Wesley
Decaestecker, Karel
Ost, Piet
Fonteyne, Valerie
De Man, Kathia
Standaert, Chloe
Rottey, Sylvie
Lumen, Nicolaas
WORLD JOURNAL OF UROLOGY, 2019, 37 (12) : 2565 - 2571
[32] Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot
Jiao, Jianhua
Zhang, Jingliang
Li, Zeyu
Wen, Weihong
Cui, Chaochao
Zhang, Qiang
Wang, Jing
Qin, Weijun
CANCER LETTERS, 2022, 548
[33] Anatomic and Molecular Imaging in Prostate Cancer
Miller, Eric T.
Salmasi, Amirali
Reiter, Robert E.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (03):
[34] Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease
Yechiel, Yaniv
Orr, Yaly
Gurevich, Konstantin
Gill, Ronit
Keidar, Zohar
CANCERS, 2023, 15 (04)
[35] A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
Zaorsky, Nicholas G.
Yamoah, Kosj
Thakur, Madhukar L.
Trabulsi, Edouard J.
Showalter, Timothy N.
Hurwitz, Mark D.
Dicker, Adam P.
Den, Robert B.
FUTURE ONCOLOGY, 2014, 10 (03) : 457 - 474
[36] Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status
Quesada-Olarte, J. M.
Allaf, M. E.
Alvarez-Maestro, M.
Martinez-Pineiro, L.
ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (06): : 386 - 399
[37] Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas
Carrete, Luis R.
Young, Jacob S.
Cha, Soonmee
FRONTIERS IN NEUROSCIENCE, 2022, 16
[38] Synchronous Prostate Cancer Incidentally Detected by FDG-PET/CT in Staging a Patient With Newly Diagnosed Nasopharyngeal Cancer
Hung, Guang-Uei
Hsiung, Ching-Yeh
Huang, Ming-Li
Lin, Shang-Tao
CLINICAL NUCLEAR MEDICINE, 2009, 34 (12) : 962 - 963
[39] A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer
De Visschere, Pieter J. L.
Standaert, Chloe
Futterer, Jurgen J.
Villeirs, Geert M.
Panebianco, Valeria
Walz, Jochen
Maurer, Tobias
Hadaschik, Boris A.
Lecouvet, Frederic E.
Giannarini, Gianluca
Fanti, Stefano
EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (01): : 47 - 76
[40] Role of PSMA PET/CT in imaging and management of prostate cancer
El Hoyek, Nadine
Shi, Xiaolei
Jenkins, Jason
Chen, Wengen
CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 233 - 239

← 1 2 3 4 5 →